Association	O
between	O
IL	B:C1334119
-	I:C1334119
4	I:C1334119
gene	I:C1334119
polymorphisms	O
,	O
interleukin	O
-	I:C0021758
4	I:C0021758
serum	O
levels	O
,	O
and	O
ankylosing	O
spondylitis	I:C0038013
.	O

Association	O
between	O
IL	O
-	I:C1334119
4	I:C1334119
gene	I:C1334119
polymorphisms	O
,	O
interleukin	B:C0021758
-	I:C0021758
4	I:C0021758
serum	O
levels	O
,	O
and	O
ankylosing	O
spondylitis	I:C0038013
.	O

Association	O
between	O
IL	O
-	I:C1334119
4	I:C1334119
gene	I:C1334119
polymorphisms	O
,	O
interleukin	O
-	I:C0021758
4	I:C0021758
serum	B:C0229671
levels	O
,	O
and	O
ankylosing	O
spondylitis	I:C0038013
.	O

Association	O
between	O
IL	O
-	I:C1334119
4	I:C1334119
gene	I:C1334119
polymorphisms	O
,	O
interleukin	O
-	I:C0021758
4	I:C0021758
serum	O
levels	O
,	O
and	O
ankylosing	B:C0038013
spondylitis	I:C0038013
.	O

We	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
two	O
common	O
polymorphisms	O
in	O
interleukin	B:C1334119
-	I:C1334119
4	I:C1334119
(	O
interleukin	O
-	I:C1334119
4	I:C1334119
)	O
on	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
and	O
the	O
development	O
of	O
ankylosing	O
spondylitis	I:C0038013
(	O
ankylosing	O
spondylitis	I:C0038013
)	O
in	O
the	O
Chinese	O
population	I:C0152035
.	O

We	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
two	O
common	O
polymorphisms	O
in	O
interleukin	O
-	I:C1334119
4	I:C1334119
(	O
interleukin	B:C1334119
-	I:C1334119
4	I:C1334119
)	O
on	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
and	O
the	O
development	O
of	O
ankylosing	O
spondylitis	I:C0038013
(	O
ankylosing	O
spondylitis	I:C0038013
)	O
in	O
the	O
Chinese	O
population	I:C0152035
.	O

We	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
two	O
common	O
polymorphisms	O
in	O
interleukin	O
-	I:C1334119
4	I:C1334119
(	O
interleukin	O
-	I:C1334119
4	I:C1334119
)	O
on	O
serum	B:C0229671
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
and	O
the	O
development	O
of	O
ankylosing	O
spondylitis	I:C0038013
(	O
ankylosing	O
spondylitis	I:C0038013
)	O
in	O
the	O
Chinese	O
population	I:C0152035
.	O

We	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
two	O
common	O
polymorphisms	O
in	O
interleukin	O
-	I:C1334119
4	I:C1334119
(	O
interleukin	O
-	I:C1334119
4	I:C1334119
)	O
on	O
serum	O
interleukin	B:C0021758
-	I:C0021758
4	I:C0021758
levels	O
and	O
the	O
development	O
of	O
ankylosing	O
spondylitis	I:C0038013
(	O
ankylosing	O
spondylitis	I:C0038013
)	O
in	O
the	O
Chinese	O
population	I:C0152035
.	O

We	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
two	O
common	O
polymorphisms	O
in	O
interleukin	O
-	I:C1334119
4	I:C1334119
(	O
interleukin	O
-	I:C1334119
4	I:C1334119
)	O
on	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
and	O
the	O
development	O
of	O
ankylosing	B:C0038013
spondylitis	I:C0038013
(	O
ankylosing	O
spondylitis	I:C0038013
)	O
in	O
the	O
Chinese	O
population	I:C0152035
.	O

We	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
two	O
common	O
polymorphisms	O
in	O
interleukin	O
-	I:C1334119
4	I:C1334119
(	O
interleukin	O
-	I:C1334119
4	I:C1334119
)	O
on	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
and	O
the	O
development	O
of	O
ankylosing	O
spondylitis	I:C0038013
(	O
ankylosing	B:C0038013
spondylitis	I:C0038013
)	O
in	O
the	O
Chinese	O
population	I:C0152035
.	O

We	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
two	O
common	O
polymorphisms	O
in	O
interleukin	O
-	I:C1334119
4	I:C1334119
(	O
interleukin	O
-	I:C1334119
4	I:C1334119
)	O
on	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
and	O
the	O
development	O
of	O
ankylosing	O
spondylitis	I:C0038013
(	O
ankylosing	O
spondylitis	I:C0038013
)	O
in	O
the	O
Chinese	B:C0152035
population	I:C0152035
.	O

A	O
total	O
of	O
420	O
inpatients	O
and	O
outpatients	O
diagnosed	B:C0011900
with	O
ankylosing	O
spondylitis	I:C0038013
were	O
enrolled	O
as	O
the	O
case	O
group	O
,	O
and	O
330	O
healthy	O
volunteers	I:C1708335
were	O
selected	O
as	O
the	O
control	O
group	O
.	O

A	O
total	O
of	O
420	O
inpatients	O
and	O
outpatients	O
diagnosed	O
with	O
ankylosing	B:C0038013
spondylitis	I:C0038013
were	O
enrolled	O
as	O
the	O
case	O
group	O
,	O
and	O
330	O
healthy	O
volunteers	I:C1708335
were	O
selected	O
as	O
the	O
control	O
group	O
.	O

A	O
total	O
of	O
420	O
inpatients	O
and	O
outpatients	O
diagnosed	O
with	O
ankylosing	O
spondylitis	I:C0038013
were	O
enrolled	O
as	O
the	O
case	O
group	O
,	O
and	O
330	O
healthy	B:C1708335
volunteers	I:C1708335
were	O
selected	O
as	O
the	O
control	O
group	O
.	O

IL	B:C1334119
-	I:C1334119
4	I:C1334119
rs2243250	I:C1334119
and	O
rs2227282	O
genotype	O
frequencies	O
in	O
the	O
latter	O
were	O
consistent	O
with	O
Hardy	O
-	O
Weinberg	O
equilibrium	O
(	O
both	O
P	O
>	O
0.05	O
)	O
.	O

IL	O
-	I:C1334119
4	I:C1334119
rs2243250	I:C1334119
and	O
rs2227282	B:C1334119
genotype	O
frequencies	O
in	O
the	O
latter	O
were	O
consistent	O
with	O
Hardy	O
-	O
Weinberg	O
equilibrium	O
(	O
both	O
P	O
>	O
0.05	O
)	O
.	O

The	O
TC	O
+	O
TT	O
genotypes	O
and	O
T	B:C0002085
allele	I:C0002085
of	O
rs2243250	O
were	O
strongly	O
associated	O
with	O
elevated	O
ankylosing	O
spondylitis	I:C0038013
risk	O
[	O
CC	O
vs	O
TC	O
+	O
TT	O
:	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
2.378	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=	O
1.746-3.239	O
,	O
P	O
<	O
0.001	O
;	O
C	O
vs	O
T	O
:	O
OR	O
=	O
2.588	O
,	O
95	O
%	O
CI	O
=	O
2.007-3.337	O
,	O
P	O
<	O
0.001	O
]	O
.	O

The	O
TC	O
+	O
TT	O
genotypes	O
and	O
T	O
allele	I:C0002085
of	O
rs2243250	B:C1334119
were	O
strongly	O
associated	O
with	O
elevated	O
ankylosing	O
spondylitis	I:C0038013
risk	O
[	O
CC	O
vs	O
TC	O
+	O
TT	O
:	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
2.378	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=	O
1.746-3.239	O
,	O
P	O
<	O
0.001	O
;	O
C	O
vs	O
T	O
:	O
OR	O
=	O
2.588	O
,	O
95	O
%	O
CI	O
=	O
2.007-3.337	O
,	O
P	O
<	O
0.001	O
]	O
.	O

The	O
TC	O
+	O
TT	O
genotypes	O
and	O
T	O
allele	I:C0002085
of	O
rs2243250	O
were	O
strongly	O
associated	O
with	O
elevated	O
ankylosing	B:C0038013
spondylitis	I:C0038013
risk	O
[	O
CC	O
vs	O
TC	O
+	O
TT	O
:	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
2.378	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=	O
1.746-3.239	O
,	O
P	O
<	O
0.001	O
;	O
C	O
vs	O
T	O
:	O
OR	O
=	O
2.588	O
,	O
95	O
%	O
CI	O
=	O
2.007-3.337	O
,	O
P	O
<	O
0.001	O
]	O
.	O

Moreover	O
,	O
the	O
rs2227282	B:C1334119
GG	O

genotype	O
and	O
G	B:C0002085
allele	I:C0002085
may	O
also	O
correlate	O
with	O
increased	O
risk	O
(	O
CC	O
vs	O
GC	O
:	O
OR	O
=	O
1.555	O
,	O
95	O
%	O
CI	O
=	O
1.130-2.141	O
,	O
P	O
=	O
0.007	O
;	O
CC	O
vs	O
GC	O
+	O
GG	O
:	O
OR	O
=	O
1.833	O
,	O
95	O
%	O
CI	O
=	O
1.357-2.476	O
,	O
P	O
<	O
0.001	O
;	O
C	O
vs	O
G	O
:	O
OR	O
=	O
1.403	O
,	O
95	O
%	O
CI	O
=	O
1.086-1.811	O
,	O
P	O
=	O
0.009	O
)	O
.	O

In	O
addition	O
,	O
serum	B:C0229671
interleukin	O
-	I:C0021758
4	I:C0021758
concentrations	O
were	O
significantly	O
lower	O
in	O
ankylosing	O
spondylitis	I:C0038013
patients	O
carrying	O
the	O
rs2243250	O
TT	O
genotype	O
compared	O
to	O
those	O
with	O
the	O
CC	O
and	O
TC	O
genotypes	O
(	O
both	O
P	O
<	O
0.05	O
)	O
.	O

In	O
addition	O
,	O
serum	O
interleukin	B:C0021758
-	I:C0021758
4	I:C0021758
concentrations	O
were	O
significantly	O
lower	O
in	O
ankylosing	O
spondylitis	I:C0038013
patients	O
carrying	O
the	O
rs2243250	O
TT	O
genotype	O
compared	O
to	O
those	O
with	O
the	O
CC	O
and	O
TC	O
genotypes	O
(	O
both	O
P	O
<	O
0.05	O
)	O
.	O

In	O
addition	O
,	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
concentrations	O
were	O
significantly	O
lower	O
in	O
ankylosing	B:C0038013
spondylitis	I:C0038013
patients	O
carrying	O
the	O
rs2243250	O
TT	O
genotype	O
compared	O
to	O
those	O
with	O
the	O
CC	O
and	O
TC	O
genotypes	O
(	O
both	O
P	O
<	O
0.05	O
)	O
.	O

In	O
addition	O
,	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
concentrations	O
were	O
significantly	O
lower	O
in	O
ankylosing	O
spondylitis	I:C0038013
patients	O
carrying	O
the	O
rs2243250	B:C1334119
TT	O
genotype	O
compared	O
to	O
those	O
with	O
the	O
CC	O
and	O
TC	O
genotypes	O
(	O
both	O
P	O
<	O
0.05	O
)	O
.	O

Similarly	O
,	O
patients	O
carrying	O
the	O
rs2227282	B:C1334119
CC	O
genotype	O
demonstrated	O
higher	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
than	O
those	O
with	O
the	O
GC	O
and	O
GG	O
genotypes	O
(	O
both	O
P	O
<	O
0.05	O
)	O
.	O

Similarly	O
,	O
patients	O
carrying	O
the	O
rs2227282	O
CC	O
genotype	O
demonstrated	O
higher	O
serum	B:C0229671
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
than	O
those	O
with	O
the	O
GC	O
and	O
GG	O
genotypes	O
(	O
both	O
P	O
<	O
0.05	O
)	O
.	O

Similarly	O
,	O
patients	O
carrying	O
the	O
rs2227282	O
CC	O
genotype	O
demonstrated	O
higher	O
serum	O
interleukin	B:C0021758
-	I:C0021758
4	I:C0021758
levels	O
than	O
those	O
with	O
the	O
GC	O
and	O
GG	O
genotypes	O
(	O
both	O
P	O
<	O
0.05	O
)	O
.	O

Our	O
study	O
provides	O
evidence	O
that	O
interleukin	B:C1334119
-	I:C1334119
4	I:C1334119
polymorphisms	O
associated	O
with	O
diminished	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
may	O
be	O
partially	O
responsible	I:C1273518
for	O
ankylosing	O
spondylitis	I:C0038013
development	O
in	O
the	O
Chinese	O
population	I:C0152035
.	O

Our	O
study	O
provides	O
evidence	O
that	O
interleukin	O
-	I:C1334119
4	I:C1334119
polymorphisms	O
associated	O
with	O
diminished	O
serum	B:C0229671
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
may	O
be	O
partially	O
responsible	I:C1273518
for	O
ankylosing	O
spondylitis	I:C0038013
development	O
in	O
the	O
Chinese	O
population	I:C0152035
.	O

Our	O
study	O
provides	O
evidence	O
that	O
interleukin	O
-	I:C1334119
4	I:C1334119
polymorphisms	O
associated	O
with	O
diminished	O
serum	O
interleukin	B:C0021758
-	I:C0021758
4	I:C0021758
levels	O
may	O
be	O
partially	O
responsible	I:C1273518
for	O
ankylosing	O
spondylitis	I:C0038013
development	O
in	O
the	O
Chinese	O
population	I:C0152035
.	O

Our	O
study	O
provides	O
evidence	O
that	O
interleukin	O
-	I:C1334119
4	I:C1334119
polymorphisms	O
associated	O
with	O
diminished	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
may	O
be	O
partially	B:C1273518
responsible	I:C1273518
for	O
ankylosing	O
spondylitis	I:C0038013
development	O
in	O
the	O
Chinese	O
population	I:C0152035
.	O

Our	O
study	O
provides	O
evidence	O
that	O
interleukin	O
-	I:C1334119
4	I:C1334119
polymorphisms	O
associated	O
with	O
diminished	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
may	O
be	O
partially	O
responsible	I:C1273518
for	O
ankylosing	B:C0038013
spondylitis	I:C0038013
development	O
in	O
the	O
Chinese	O
population	I:C0152035
.	O

Our	O
study	O
provides	O
evidence	O
that	O
interleukin	O
-	I:C1334119
4	I:C1334119
polymorphisms	O
associated	O
with	O
diminished	O
serum	O
interleukin	O
-	I:C0021758
4	I:C0021758
levels	O
may	O
be	O
partially	O
responsible	I:C1273518
for	O
ankylosing	O
spondylitis	I:C0038013
development	O
in	O
the	O
Chinese	B:C0152035
population	I:C0152035
.	O

